{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:30:58Z","timestamp":1760239858080,"version":"build-2065373602"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology\/Oncology Clinics of North America"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.hoc.2020.07.002","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T08:59:52Z","timestamp":1601542792000},"page":"997-1008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Spectrum of Monoclonal Immunoglobulin-Associated Diseases"],"prefix":"10.1016","volume":"34","author":[{"given":"Sascha A.","family":"Tuchman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Zonder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.hoc.2020.07.002_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1053\/j.seminoncol.2016.11.004","article-title":"Multiple myeloma epidemiology and survival: a unique malignancy","volume":"43","author":"Kazandjian","year":"2016","journal-title":"Semin Oncol"},{"issue":"10","key":"10.1016\/j.hoc.2020.07.002_bib2","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1182\/bloodadvances.2018016402","article-title":"Epidemiology of AL amyloidosis: a real-world study using US claims data","volume":"2","author":"Quock","year":"2018","journal-title":"Blood Adv"},{"issue":"22","key":"10.1016\/j.hoc.2020.07.002_bib3","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A\u00a0monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"issue":"21","key":"10.1016\/j.hoc.2020.07.002_bib4","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1182\/blood.V118.21.1827.1827","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) precedes the diagnosis of AL amyloidosis by up to 14 years","volume":"118","author":"Weiss","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.hoc.2020.07.002_bib5","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.hoc.2020.07.002_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ajh.25292","article-title":"Waldenstr\u00f6m macroglobulinemia: 2019 update on diagnosis, risk stratification, and management","volume":"94","author":"Gertz","year":"2019","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.hoc.2020.07.002_bib7","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajh.20157","article-title":"Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement","volume":"77","author":"Asatiani","year":"2004","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.hoc.2020.07.002_bib8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/ajh.21814","article-title":"Two distinct syndromes of lymphoma-associated AL amyloidosis: a case series and review of the literature","volume":"85","author":"Telio","year":"2010","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2020.07.002_bib9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0609.1986.tb02644.x","article-title":"Monoclonal Bence Jones proteinuria in chronic lymphocytic leukaemia","volume":"36","author":"Pezzoli","year":"1986","journal-title":"Scand J Haematol"},{"issue":"8","key":"10.1016\/j.hoc.2020.07.002_bib10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.leukres.2010.12.005","article-title":"Prognostic significance of serum immunoglobulin paraprotein in patients with chronic lymphocytic leukemia","volume":"35","author":"Xu","year":"2011","journal-title":"Leuk Res"},{"issue":"10","key":"10.1016\/j.hoc.2020.07.002_bib11","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1182\/blood-2011-04-349134","article-title":"Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia","volume":"118","author":"Maurer","year":"2011","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.hoc.2020.07.002_bib12","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2012-07-445304","article-title":"Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificant","volume":"120","author":"Leung","year":"2012","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.hoc.2020.07.002_bib13","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/ki.1994.355","article-title":"Monoclonal immunoglobulin deposition disease (Randall type). Relationship with structural abnormalities of immunoglobulin chains","volume":"46","author":"Preud'homme","year":"1994","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.hoc.2020.07.002_bib14","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5414\/CN108319","article-title":"Light chain deposition disease and proximal tubulopathy in two successive kidney allografts","volume":"83","author":"Drieux","year":"2015","journal-title":"Clin Nephrol"},{"issue":"6","key":"10.1016\/j.hoc.2020.07.002_bib15","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1016\/j.kint.2017.08.010","article-title":"Trifecta of light chain cast nephropathy, monoclonal plasma cell infiltrates, and light chain proximal tubulopathy","volume":"92","author":"Koratala","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.hoc.2020.07.002_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12882-017-0584-8","article-title":"Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma","volume":"18","author":"Wu","year":"2017","journal-title":"BMC Nephrol"},{"issue":"2","key":"10.1016\/j.hoc.2020.07.002_bib17","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-9343(76)90440-X","article-title":"Manifestations of systemic light chain deposition","volume":"60","author":"Randall","year":"1976","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.hoc.2020.07.002_bib18","first-page":"281","article-title":"Renal disease and patient survival in light chain deposition disease","volume":"43","author":"Pozzi","year":"1995","journal-title":"Clin Nephrol"},{"issue":"4","key":"10.1016\/j.hoc.2020.07.002_bib19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/bjh.14279","article-title":"Renal disease related to Waldenstr\u00f6m macroglobulinaemia: incidence, pathology and clinical outcomes","volume":"175","author":"Vos","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.hoc.2020.07.002_bib20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1470-2045(04)01495-0","article-title":"Nodal marginal-zone lymphoma associated with monoclonal light-chain and heavy-chain deposition disease","volume":"5","author":"Went","year":"2004","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.hoc.2020.07.002_bib21","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1182\/blood-2018-09-872028","article-title":"Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study","volume":"133","author":"Joly","year":"2019","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.hoc.2020.07.002_bib22","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/ajh.24528","article-title":"Outcomes of patients with renal monoclonal immunoglobulin deposition disease","volume":"91","author":"Kourelis","year":"2016","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2020.07.002_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.bbmt.2017.08.031","article-title":"High-dose melphalan and stem cell transplantation in patients on dialysis due to immunoglobulin light-chain amyloidosis and monoclonal immunoglobulin deposition disease","volume":"24","author":"Batalini","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.hoc.2020.07.002_bib24","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1182\/bloodadvances.2020001553","article-title":"Daratumumab in light chain deposition disease: rapid and profound hematologic response preserves kidney function","volume":"4","author":"Milani","year":"2020","journal-title":"Blood Adv"},{"issue":"36","key":"10.1016\/j.hoc.2020.07.002_bib25","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.hoc.2020.07.002_bib26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0002-9343(75)90601-4","article-title":"Fanconi syndrome in adults. A manifestation of a latent form of myeloma","volume":"58","author":"Maldonado","year":"1975","journal-title":"Am J Med"},{"issue":"11","key":"10.1016\/j.hoc.2020.07.002_bib27","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1038\/modpathol.2011.104","article-title":"The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation","volume":"24","author":"Larsen","year":"2011","journal-title":"Mod Pathol"},{"issue":"9","key":"10.1016\/j.hoc.2020.07.002_bib28","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.5858\/2007-131-1368-ETPSOI","article-title":"Expanding the pathologic spectrum of immunoglobulin light chain proximal tubulopathy","volume":"131","author":"Kapur","year":"2007","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"10.1016\/j.hoc.2020.07.002_bib29","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.2003.00853.x","article-title":"Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features","volume":"63","author":"Rosenstock","year":"2003","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.hoc.2020.07.002_bib30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0272-6386(12)70138-5","article-title":"Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy","volume":"22","author":"Fogo","year":"1993","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1016\/j.hoc.2020.07.002_bib31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0272-6386(96)90098-0","article-title":"The racial prevalence of glomerular lesions in nephrotic adults","volume":"27","author":"Korbet","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.hoc.2020.07.002_bib32","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1053\/j.ajkd.2015.08.003","article-title":"AJKD atlas of renal pathology: immunotactoid glomerulopathy","volume":"66","author":"Fogo","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"7","key":"10.1016\/j.hoc.2020.07.002_bib33","doi-asserted-by":"crossref","first-page":"e229751","DOI":"10.1136\/bcr-2019-229751","article-title":"Case of immunotactoid glomerulopathy showing high responsiveness to steroids therapy despite severe pathological features","volume":"12","author":"Ohashi","year":"2019","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.hoc.2020.07.002_bib34","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10157-009-0166-6","article-title":"A\u00a0case of immunotactoid glomerulopathy exhibiting nephrotic syndrome successfully treated with corticosteroids and antihypertensive therapy","volume":"13","author":"Kinomura","year":"2009","journal-title":"Clin Exp Nephrol"},{"issue":"9","key":"10.1016\/j.hoc.2020.07.002_bib35","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.transproceed.2009.03.100","article-title":"A\u00a0case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab","volume":"41","author":"Sathyan","year":"2009","journal-title":"Transplant Proc"},{"issue":"12","key":"10.1016\/j.hoc.2020.07.002_bib36","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00277-007-0330-6","article-title":"Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation","volume":"86","author":"Witzens-Harig","year":"2007","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.hoc.2020.07.002_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semnephrol.2011.06.005","article-title":"Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification","volume":"31","author":"Sethi","year":"2011","journal-title":"Semin Nephrol"},{"issue":"5","key":"10.1016\/j.hoc.2020.07.002_bib38","doi-asserted-by":"crossref","first-page":"770","DOI":"10.2215\/CJN.06760909","article-title":"Membranoproliferative glomerulonephritis secondary to monoclonal gammopathy","volume":"5","author":"Sethi","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.hoc.2020.07.002_bib39","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.kint.2018.02.020","article-title":"A\u00a0clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits","volume":"94","author":"Gumber","year":"2018","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.hoc.2020.07.002_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.410300111","article-title":"Neuropathy associated with monoclonal gammopathies of undetermined significance","volume":"30","author":"Gosselin","year":"1991","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.hoc.2020.07.002_bib41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0022-510X(93)90300-N","article-title":"Antiglycolipid antibodies, immunoglobulins and paraproteins in motor neuron disease: a population based case-control study","volume":"114","author":"Willison","year":"1993","journal-title":"J\u00a0Neurol Sci"},{"issue":"Pt 4","key":"10.1016\/j.hoc.2020.07.002_bib42","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/brain\/123.4.710","article-title":"Long-term prognosis of neuropathy associated with anti-MAG IgM M-proteins and its relationship to immune therapies","volume":"123","author":"Nobile-Orazio","year":"2000","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.hoc.2020.07.002_bib43","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ana.410360313","article-title":"Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy","volume":"36","author":"Nobile-Orazio","year":"1994","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.hoc.2020.07.002_bib44","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1212\/WNL.54.3.615","article-title":"Distal acquired demyelinating symmetric neuropathy","volume":"54","author":"Katz","year":"2000","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.hoc.2020.07.002_bib45","article-title":"Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies","author":"Lunn","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"Pt 10","key":"10.1016\/j.hoc.2020.07.002_bib46","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1093\/brain\/124.10.1968","article-title":"The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies","volume":"124","author":"Willison","year":"2001","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.hoc.2020.07.002_bib47","first-page":"1168","article-title":"Successful treatment of CANOMAD with IVIg and rituximab","volume":"260","author":"L\u00f6scher","year":"2013","journal-title":"J\u00a0Neurol"},{"issue":"2","key":"10.1016\/j.hoc.2020.07.002_bib48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/jnnp-2019-321532","article-title":"Multifocal motor neuropathy: controversies and priorities","volume":"91","author":"Yeh","year":"2020","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.hoc.2020.07.002_bib49","article-title":"Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy","author":"Umapathi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.hoc.2020.07.002_bib50","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/ncpneuro0917","article-title":"Neurological manifestations of Waldenstr\u00f6m macroglobulinemia","volume":"4","author":"Baehring","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"issue":"6","key":"10.1016\/j.hoc.2020.07.002_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10428194.2020.1711901","article-title":"Waldenstrom's macroglobulinemia in the era of immunotherapy","volume":"61","author":"Vaxman","year":"2020","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.hoc.2020.07.002_bib52","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0022-510X(99)00049-0","article-title":"Clinical features and anti-neural reactivity in neuropathy associated with IgG monoclonal gammopathy of undetermined significance","volume":"164","author":"Di Troia","year":"1999","journal-title":"J\u00a0Neurol Sci"},{"issue":"21","key":"10.1016\/j.hoc.2020.07.002_bib53","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1056\/NEJM199111213252105","article-title":"Plasma exchange in polyneuropathy associated with monoclonal gammopathy of undetermined significance","volume":"325","author":"Dyck","year":"1991","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.hoc.2020.07.002_bib54","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V87.4.1458.bloodjournal8741458","article-title":"Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome","volume":"87","author":"Gherardi","year":"1996","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.hoc.2020.07.002_bib55","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ajh.24802","article-title":"POEMS syndrome: 2017\u00a0Update on diagnosis, risk stratification, and management","volume":"92","author":"Dispenzieri","year":"2017","journal-title":"Am J Hematol"},{"issue":"10","key":"10.1016\/j.hoc.2020.07.002_bib56","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1182\/blood-2004-05-2046","article-title":"Peripheral blood stem cell transplantation in 16 patients with POEMS syndrome, and a review of the literature","volume":"104","author":"Dispenzieri","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.hoc.2020.07.002_bib57","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ajh.23374","article-title":"Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients","volume":"88","author":"Royer","year":"2013","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.hoc.2020.07.002_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/jdv.13847","article-title":"Monoclonal gammopathy of cutaneous significance: review of a relevant concept","volume":"31","author":"Lipsker","year":"2017","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"12","key":"10.1016\/j.hoc.2020.07.002_bib59","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.2215\/CJN.02980316","article-title":"Paraprotein-related kidney disease: glomerular diseases associated with paraproteinemias","volume":"11","author":"Motwani","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.hoc.2020.07.002_bib60","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1056\/NEJMc1106670","article-title":"The TEMPI syndrome--a novel multisystem disease","volume":"365","author":"Sykes","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.hoc.2020.07.002_bib61","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJMc1202649","article-title":"Bortezomib to treat the TEMPI syndrome","volume":"366","author":"Kwok","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"12","key":"10.1016\/j.hoc.2020.07.002_bib62","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1038\/leu.2015.298","article-title":"Long-term complete clinical and hematological responses of the TEMPI syndrome after autologous stem cell transplantation","volume":"29","author":"Kenderian","year":"2015","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.hoc.2020.07.002_bib63","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1056\/NEJMc1804415","article-title":"Complete responses in the TEMPI syndrome after treatment with daratumumab","volume":"378","author":"Sykes","year":"2018","journal-title":"N\u00a0Engl J Med"}],"container-title":["Hematology\/Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858820300794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889858820300794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:16:38Z","timestamp":1760184998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889858820300794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0889858820300794"],"URL":"https:\/\/doi.org\/10.1016\/j.hoc.2020.07.002","relation":{},"ISSN":["0889-8588"],"issn-type":[{"type":"print","value":"0889-8588"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Spectrum of Monoclonal Immunoglobulin-Associated Diseases","name":"articletitle","label":"Article Title"},{"value":"Hematology\/Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hoc.2020.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}